Evaluation of Clostridium difficile-Associated Diarrhea With a Drug Formulary Change in Preferred Fluoroquinolones

BACKGROUND: Recent publications report that gatifloxacin might be associated with a greater incidence of Clostridium difficile-associated diarrhea (C. difficile, CDAD) than are other fluoroquinolones. We performed a drug use evaluation to examine this issue after adding gatifloxacin to the formulary...

Descripción completa

Detalles Bibliográficos
Autores principales: Walbrown, Molly A., Aspinall, Sherrie L., Bayliss, Nichole K., Stone, Roslyn A., Cunningham, Francesca, Squier, Cheryl L., Good, Chester B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2008
Materias:
Formulary Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437373/
https://www.ncbi.nlm.nih.gov/pubmed/18240880
http://dx.doi.org/10.18553/jmcp.2008.14.1.34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437373/
https://www.ncbi.nlm.nih.gov/pubmed/18240880
http://dx.doi.org/10.18553/jmcp.2008.14.1.34

Ejemplares similares